Selective Enrichment of Cysteine-Containing Phosphopeptides for Subphosphoproteome Analysis by Mingming Dong (1471396)

“…Interestingly, amino acid residues surrounding the identified phosphosites were enriched with buried residues (L, V, A, C) while depleted with exposed residues (D, E, R, K). …”

Role of flagellin in intraocular inflammation. by Salai Madhumathi Parkunan (588242)

“…<i>B. cereus</i> flagellin was a weak TLR5 agonist, resulting in significantly less NFκB activity at comparable flagellin concentrations (mean ±SD for two repeated experiments, *P≤0.001).…”

Methylation-sensitive expression of <i>ROS1</i> is evolutionarily conserved. by Ben P. Williams (715604)

“…(<b>E</b>) Relative <i>AlROS1a</i> transcripts are significantly decreased when plants are grown on 5-azaC. …”

Functional characterization of hourglass shape. by Noa Liscovitch (108538)

“…(A) <i>Neuron migration</i> shows decreasing dissimilarity (B) <i>Learning or memory</i> shows a post-natal increase in dissimilarity. …”

RNAi-based DtSER-1 deorphanization. by Mostafa Zamanian (315563)

“…<i>DtSER-1</i> knockdown corresponds to significantly decreased cAMP stimulation (∼32%) in response to 5-HT. …”

Effect of DNA methylation or de-methylation on <i>Pax6</i> gene expression. by Jie Gao (10266)

“…<p><b><i>(A)</i></b> Effect of decreasing DNA methylation on <i>Pax6</i> gene expression in ES cells. …”

Image_1_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

DataSheet_1_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.docx by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

Viral replicative advantages and pathological consequences related to STAT3-altered function. by Armando Andres Roca Suarez (4967134)

“…ANGPTL4, angiopoietin-like protein 4; APR, acute phase response; BIRC5, baculoviral IAP repeat-containing protein 5; CCL5, C-C motif chemokine ligand 5; DCs, dendritic cells; DC-SIGN, dendritic cell-specific ICAM-3-grabbing non-integrin 1; EBV, Epstein–Barr virus; FOS, proto-oncogene c-Fos; HCC, hepatocellular carcinoma; HCMV, human cytomegalovirus; HCV, hepatitis C virus; HEV, hepatitis E virus; HSCs, hepatic stellate cells; IAV, influenza A virus; IDO1, indoleamine 2,3-dioxygenase 1; IL-10, interleukin 10; ISG, interferon-stimulated gene; JUN, proto-oncogene c-Jun; KSHV, Kaposi’s sarcoma-associated herpesvirus; MCL1, induced myeloid leukemia cell differentiation protein Mcl-1; MDSCs, myeloid-derived suppressor cells; MT, microtubule; MUC1, mucin 1 cell surface associated; MuV, mumps virus; NPC, nasopharyngeal carcinoma; NR4A2, nuclear receptor subfamily 4 group A member 2; PCBP2, poly(rC)-binding protein 2; PD-L1, programmed cell death 1 ligand 1; RTA, R transactivator; RVFV, Rift Valley fever virus; STAT3, signal transducer and activator of transcription 3; TGF-β, transforming growth factor beta; T_reg, regulatory CD4⁺ T cell; VZV, varicella-zoster virus.…”

Image_3_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

Image_4_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

Image_2_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

Week 6 & 7 Experimental Design: Impact of the Anthropocene on bug abundance by Naduni Kurukulasooriya (795949)

“…Every 5 meters was considered a new group, the first 5 meters was Group 1 and the last was Group 6. …”

OLE reduces plaque burden in the cortex and hippocampus of TgCRND8 mice. by Cristina Grossi (358570)

“…Both Aβ40 and Aβ42 levels were significantly decreased in OLE-fed Tg versus age-matched untreated Tg (n<i> = </i>5/group) mice. …”

Schematic diagram of the electrochemical detection protocol adopted in this study. by Amanda Giamberardino (484995)

Visualization 1 - Improvement in vascular contrast with an axial displacement of detector.avi by Andres Guevara-Torres (5543636)

Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

“…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”

Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

“…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”

Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

“…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”

Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

“…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”